Direct killing of interleukin-2-transfected tumor cells by human neutrophils

International Journal of Cancer

Volumn 66, Issue 3, 1996, Pages 367-373

  Pericle, Federica ^a   Kirken, Robert A ^b   Epling Burnette, P K ^c   Blanchard, D Kay ^c   Djeu, Julie Y ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL; PRIORITY JOURNAL; TUMOR CELL DESTRUCTION;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIVISION; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; HUMANS; INTERLEUKIN-2; KANAMYCIN KINASE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEUTROPHILS; PHAGOCYTOSIS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, INTERLEUKIN-2; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029973284     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960503)66:3<367::AID-IJC17>3.0.CO;2-8     Document Type: Article

References (37)

1. BLANKEMSTEIN, T., QIN, Z., UBERLA, K., MULLER, W., ROSEN, H., VOLK, H.D. and DIAMANSTEIN, T., Tumor suppression after tumor cell-targeted tumor necrosis α gene transfer. J exp. Med., 173, 1047-1052 (1991).
2. BRUNETTI, M., MUSIANI, P., MODICA, A., FORNI, G., NANNI, P., PERICLE, F., FERRARA, G. and MODESTI, A., Various cytokines (IL-2, IL-4, IFN-γ) show different efficiency in inducing tumor rejection. In: A. Cittadini (ed.). Molecular oncology and clinical application, pp. 235-241, Birkhauser, Basle (1993).
3. CAMERON, D.J., A comparison of the cytotoxic potential in polymorphonuclear leukocytes obtained from normal donors and cancer patients. Clin. Immimol. Immunopathol., 28, 115-124 (1983).
4. + T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2. J Immunol., 149, 3627-3635 (1992).
5. CERMERLIC, D., DADEY, B., HAN, T. and VAICKUS, L., Cytokine influence on killing of fresh chronic lymphocytic leukemia cells by human leukocytes. Blood, 77, 2707-2715 (1991)
6. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem., 162, 156-159 (1987).
7. COLOMBO, M.P., MODESTI, A., PARMIANI, G. and FORNI, G., Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res., 52, 4853-4856 (1992).
8. COLOTTA, F., RE, F., POLENTARUTTI, N., SOZZANI, S. and MANTOVANI, A., Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood, 80, 2012-2020 (1992).
9. CORTESINA, G., DE STEFANI, A., GIOVARELLI, M., BARIOGLIO, M.G., CAVALLO, G.P., JEMMA, C. and FORNI, G., Treatment of recurrent squamous cell carcinoma of head and neck with low doses of interleukin-2 injected perilymphatically. Cancer, 62, 2482-2485 (1988).
10. COX, W.G., MELILLO, G., CHAITOPADHYAY, U., MULLET, D., FERTEL, R.H. and VARESIO, L., Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediates IFN-γ plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol., 149, 3290-3296 (1992).
11. DJEU, J.Y., LIU, J.H., WEI, S., RUI, H., PEARSON, C.A., LEONARD, W.J. and BLANCHARD, D.K . Function associated with interleukin-2 receptor-β on human neutrophils. J. Immunol., 150, 960-970 (1993).
12. DY, C., REISSER, D. and MARTIN, F., Non-activated rat neutrophils kill syngeneic colon tumor cells by the release of low molecular weight factor. Immunobiology, 181, 1-12 (1990).
13. HIBBS, J.B., WESTENFELDER, C., TAINOR, R., VAVRIN, Z., KABLITZ, C., BARANOWSKI, R.L., WARD, J.H., MENLOVE, R.L., MCMURRY, M.P., KUSHNER, J.P. and SAMLOWSKI, W.E., Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2therapy. J. clin. Invest, 89, 867-877 (1992).
14. KOREC, S., HERBERMAN, R.B., DEAN, J.H. and CANNON, G.B., Cytostasis of tumor cell lines by human granulocytes. Cell. Immunol., 53, 104-115 (1980).
15. KUSHNER, B.H. and CHEUNG, N.V., Absolute requirement of CD11/ CD18 adhesion molecules, FcRII. and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophils anti-human tumor cytotoxicity. Blood, 79, 1484-1490 (1992).
16. LICHTENSTEIN, A., GANZ, T., NGUYEN, T., SELSTED, M.E. and LEHRER, R.I., Mechanism of target cytolysis by peptide defensins. J. Immunol., 140, 2686-2694 (1988).
17. LICHTENSTEIN, A. and KAHLE, J., Antitumor effect of inflammatory neutrophils: characteristics of in vivo generation and in vitro tumor cell lysis. Int. J Cancer, 35, 121-127 (1985).
18. LIU, J.H., WEI, S., USSERY, D., EPLING-BURNETTE, P.K., LEONARD, W. and DIEU, J.Y., Expression of interleukin-2 receptor γ chain on human neutrophils. Blood, 84, 3870-3875 (1994).
19. MALAWISTA, S.E., MONTGOMERY, R.R. and VAN BLARICOM, G., Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. J. clin. Invest., 90, 631-636 (1992).
20. MCBRIDE, W.H , THACKER, J.D., COMORA, S., ECONOMOU. J.S., KELLEY, D., HOGGE, D., DUBINETT, S.M. and DOUGHERTY, G.J., Genetic modification of a murine fibrosarcoma to produce interleukin-7 stimulates host cell infiltration and tumor immunity. Cancer Res., 52, 3931-3937 (1992).
21. MCCALL, T.B., FEELISCH, M., PALMER, R.M.J. and MOCADA, S., Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Brit. J. Pharmacol., 102, 234-238 (1991).
22. MIDORIKAMA, Y., YAMASHITA, T. and SENDO, F., Modulation of the immune response to transplanted tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody: abrogation of specific transplantation resistance to chemical carcinogen-induced syngeneic tumors by selective depletion of neutrophils in vivo. Cancer Res., 50, 6243-6247 (1990).
23. SMANN, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63 (1983).
24. MULLIGAN, M.S., HEVEL, J.M., MARLETTA, M. and WARD, P.A., Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. nat. Acad. Sci. (Wash.), 88, 6338-6342 (1991).
25. MURAO, S., STEVENS, F.J., ITO, A. and HUBERMAN, E., Myeloperoxidase: a myeloid cell nuclear antigen with DNA-binding properties. Proc. nat. Acad Sci. (Wash.), 85, 1232-1236 (1988).
26. MUSIANI, P. and 13 OTHERS, Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interieukin-2 interleukin-4 or interferon-γ genes. Nat. Immunol., 13, 93-101 (1994).
27. NANNI, P., DE GIOVANNI, C., LOLLINI, P.L., NICOLETTI, G. and PRODI, G., TS/A: a new metastasizing cell line originated from BALB/c spontaneous mammary adenocarcinoma. Clin. exp. Metastasis, 1, 373-376 (1983).
28. PERICLE, F., DI PIERRO, F. and FORNI, G., Clinical trials with local administration of lymphohaematopoietic growth factors. In: R. Mertelmasnn (ed.), Lymphohaematopoietic growth factors II, pp. 87-93. Springer-Verlag, Berlin (1992).
29. + lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J. Immunol., 153, 5659-5673 (1995).
30. PERICLE, F., LIU, J.H., DIAZ, J.I., BLANCHARD, D.K., WEI, S., FORNI, G. and DJEU, Y.J., Interleukin-2 prevention of apoptosis in human neutrophils. Europ. J. Immunol., 24, 440-444 (1994).
31. SALVEMINI, D.G., DE NUCCI, G., GRYGLEWSKLI, R.J. and VANE, J.R., Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc. nat. Acad. Sci. (Wash.), 86, 6328-6332 (1989).
32. STOPPACCIARO, A., MELANI, C., PARENZA, M., MASTRACCHIO, A., BASSI,. C., BARONI, C., PARMIANI, G. and COLOMBO, M., Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon-γ. J. exp. Med., 178, 151-161 (1993).
33. TEPPER, R.I., COFFMAN, R.L. and LEDER, P., An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science, 257, 548-551 (1992).
34. VALERIUS, T., REPP, R., DE WIT, T.P.M., BERTHOLD, S., PLATZER, E., KALDEN, J.R., GRAMATZKI, M. and VAN DE WINKEL, J.G.J., Involvement of the high-affinity receptor for IgG (FcγRI; CD64) in enhanced tumor cell cytotoxicity of neutrophil during granulocyte colonystimulating factor therapy. Blood, 82, 931-939 (1993).
35. VAN KESSEL, K.P.M. and VERHOEF, J., A view to a kill: cytotoxic mechanisms of human polymorphonuclear leukocytes compared with monocytes and natural killer cells. Pathobiology, 58, 249-264 (1990).
36. WEI, S., BLANCHARD, D.K., LIU, J.H., LEONARD, W.J. and DJEU, J.Y., Activation of tumor necrosis factor-α production from human neutrophils by IL-2 via IL-2Rβ. J. Immunol., 150, 1979-1987 (1993).
37. WEI, S., LIU, J.H., BLANCHARD, D.K. and DJEU, J.Y., Induction of IL-8 gene expression in human polymorphonuclear neutrophils by recombinant IL-2. J. Immunol., 152, 3630-3636 (1994).